Sysmex (OTCMKTS:SSMXY) Shares Gap Up - Here's What Happened

Key Points

• Sysmex Corporation shares gapped up prior to trading on Monday, opening at $13.30 after closing at $12.72, with a trading volume of 207 shares.
• Zacks Research has upgraded Sysmex from a "strong sell" rating to a "hold" rating, with analysts currently maintaining a consensus rating of "Hold" for the stock.
• In its latest earnings report, Sysmex missed earnings expectations, reporting $0.05 EPS against a consensus estimate of $0.12, with revenues of $717.09 million compared to the estimated $807.27 million.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report)'s stock price gapped up prior to trading on Monday . The stock had previously closed at $12.72, but opened at $13.30. Sysmex shares last traded at $13.30, with a volume of 207 shares changing hands.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Sysmex from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 14th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has an average rating of "Hold".

Sysmex Price Performance

The company has a current ratio of 3.37, a quick ratio of 2.49 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $7.90 billion, a P/E ratio of 25.10 and a beta of 1.10. The company has a fifty day simple moving average of $14.38 and a two-hundred day simple moving average of $16.64.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.12 by ($0.07). Sysmex had a return on equity of 10.20% and a net margin of 9.35%.The business had revenue of $717.09 million for the quarter, compared to the consensus estimate of $807.27 million. Sell-side analysts expect that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.